Susan Alderman
PhD, RN
Assistant Professor
Department of Graduate Studies
Susan Alderman, PhD, RN, has been a registered nurse since 1987, specializing in acute care and research. She has a Master’s in Nursing Education and her PhD in Nursing with a research focus on cognitive recovery after stroke. She currently serves as nursing faculty at Cizik School of Nursing and as Clinical Research Director at the Institute for Stroke and Cerebrovascular Disease, at the McGovern Medical School. She currently serves as a manuscript reviewer for several neurology journals.
She has worked as a nurse researcher for the Department of Neurology, Stroke Team at the McGovern Medical School from 2008 to 2014. Dr. Alderman has worked on various industry and NIH trials, including the first US trial using stem cells to treat acute stroke. She has presented her research at numerous national and international conferences. Her dissertation work received substantial support from the Partner’s Nursing scholarship program. As a NIH StrokeNet trainee/Fellow (2016-2017), she received continued funding for her research in cognitive impairment after acute stroke.
Education
Cizik School of Nursing at the University of Texas Health Science Center, Houston, Texas
Doctor of Philosophy in Nursing
May 2016
Texas Woman’s University, Houston, Texas
Master of Science in Nursing Education
August 2012
Texas Woman’s University, Houston, Texas
Bachelor of Science in Nursing
December 2000
Lone Star College
Associate Degree in Nursing
May 1987
Clinical/Research Focus
Dr. Alderman has focused her research activities on creating and facilitating acute stroke and stroke recovery studies. She manages a team of eleven research staff involved in drug, stem cell, speech and occupational therapy and device studies for the Stroke Institute
Publications
- Rehabilitation Therapy Doses Are Low After Stroke and Predicted by Clinical Factors
- Longitudinal neuroimaging evaluation of the corticospinal tract in patients with stroke treated with autologous bone marrow cells
- Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial
- Cognitive deficits in acute mild ischemic stroke and TIA and effects of rt-PA
- Ongoing Secondary Degeneration of the Limbic System in Patients With Ischemic Stroke: A Longitudinal MRI Study